PAVmed Inc. Warrant
PAVMW
PAVMW was delisted on the 28th of January, 2022.
4 hedge funds and large institutions have $130K invested in PAVmed Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
900% more capital invested
Capital invested by funds: $13K → $130K (+$117K)
33% more funds holding
Funds holding: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$93.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$459 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Wolverine Asset Management
Chicago,
Illinois
| $126K | +$93.4K | +53,790 | +702% |
|
|
2
UBS Group
Zurich,
Switzerland
| $3K | +$459 | +264 | +20% |
|
|
AF
3
Allworth Financial
Folsom,
California
| $1K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | +$2 | +1 | New |
|
PAVMW Hedge Fund Activity: Q2 2021 in Review
4 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q2 2021, worth a combined $130K — up 900% from $13K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PAVMW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $93.4K.
- 4 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q2 2021, up from 3 in Q1 2021.
- Funds reported $130K of PAVmed Inc. Warrant stock for Q2 2021, up 900% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Warrant positions in Q2 2021 and 0 closed out, a net change of +1 holder.
- The largest PAVmed Inc. Warrant buyer in Q2 2021 was Wolverine Asset Management, an estimated $93.4K added.
Based on aggregated 13F filings for Q2 2021.